Visible Spectrophotometric Determination of Lamivudine in Tablet Dosage Form

 

Lakshmi Aswini G.1*, Dhachinamoorthi D.2 and Prasada Rao CH.2

1Dept. of Pharmaceutical Analysis, Vagdevi College of Pharmacy, Gurazala -522415, India.

2Dept. of Pharmaceutical Analysis, QIS College of Pharmacy, Ongole -523272, India.

*Corresponding Author E-mail: aswinipharmagl@gmail.com

 

ABSTRACT:

A simple visible spectrophotometric method has been developed for the estimation of Lamivudine in bulk and tablet dosage form. This method is based on the diazotization of Lamivudine with nitrous acid to form diazotized Lamivudine, followed by its coupling with β-naphthol to form a red coloured chromogen which shows maximum absorption at 553.0 nm and obeys Beer’s law in the concentration range of 5-20 mcg/ml. This method was validated for accuracy, precision and ruggedness. Statistical analysis proves that the method is reproducible and selective for the estimation of said drug.

 

KEYWORDS: Visible spectrophotometry; Lamivudine; β-naphthol; Validation.

 


 

INTRODUCTION:

Lamivudine is a nucleoside reverse transcriptase inhibitor used in the treatment of AIDS. Chemically Lamivudine is (1R, cis)-4-amino-1-(1-hydroxy methyl-1, 3-oxathiolan-5-yl)- (1H)-pyrimidine-1-one1. A very few analytical methods appeared in the literature for the determination of Lamivudine includes its estimation with other drugs2-9. There is no reported method on spectrophotometry and therefore, require much more investigation. The proposed method is based on the visible spectrophotometric technique.

 

MATERIAL AND METHODS:

A Systronics UV-Vis double beam spectrophotometer (model 2201) with 1 cm matched quartz cells was used for all spectral measurements. All the chemicals used in the investigation were of analytical grade. Authentic drug sample of Lamivudine was given as a gift sample by Hetero drugs limited, Hyderabad. Tablets of Lamivudine are procured from local market.

 

Working Standard Solution of Lamivudine:

Standard stock solution was prepared by dissolving accurately weighed, 100mg of Lamivudine in distilled water and the volume was made upto 100ml with distilled water (stock solution-I, 1000 mcg/ml).From this, a working standard solution containing 100 mcg/ml was prepared with distilled water.

 

Sample Preparation of Lamivudine:

20 tablets of two different brands of Lamivudine were weighed and powdered in glass mortar and the powder equivalent to 25 mg of Lamivudine was weighed accurately and transferred into a 25 ml standard volumetric flask. The contents were dissolved in distilled water and sonicated for five minutes. This solution was filtered through 0.45 µWhatmann filter paper. 5 ml of the filtrate was diluted to 50 ml with distilled water to get the solution of 100 mcg/ml.

 

Development of colour and study of spectra in visible region:

Aliquots of standard solution of Lamivudine ranging from 0.5 to 2.0 ml (1 ml = 100 µg) were transferred into a series of 10 ml volumetric flasks. To each flask, 1.0 ml of hydrochloric acid (2 N) and 1.0 ml of sodium nitrite (0.1% w/v) was added and a reaction time of 10 min at 0-5°C was given for the completion of reaction. Then 1.0 ml of alkaline β-naphthol solution (0.1% w/v in 2% aqueous NaOH) was added to each flask with gently shaking and after 10 min, the volume in each flask was made up to 10 ml with distilled water. The absorbances of red coloured chromogen were measured at 553.0 nm against the reagent blank. The coloured chromogen was stable for 3 h. The amount of Lamivudine present in the sample solution was computed from the respective calibration curve.

 

Fig. 01- Absorption Spectrum of Lamivudine with β-naphthol.

 

RESULTS AND DISCUSSION:

In the present investigation the λmax of the Lamivudine was found to be 553.0 nm. Lamivudine follows linearity in the concentration range of 5- 20 mcg/ml. Two brands of tablets were analyzed and amount of drug were determined by proposed method; it was in good agreement with the label claim. The proposed method was validated as per the ICH guidelines. The recovery studies were carried out by adding a known amount of drug to pre analysed sample at two different levels and the % recoveries were ranges from 99.74-99.95%, which shows the accuracy of method. Intra-day and Inter-day precision of the assay was determined by analyzing the drug sample using same concentration. The intra-day and inter-day % RSD values were calculated and lying in the range of 1.121-1.261%. Ruggedness of proposed method was studied with the help of two different analysts and results were evaluated by calculating the % RSD values; lying within the range of 1.193-1.235%.

 

RESULTS OF ANALYSIS:

Table 01: Optimum conditions, optical characteristics and statistical data of the regression equation in the proposed method

Parameter

Values

lmax (nm)

553

Beer’s law limits (mcg/ml)

5-20

Molar extinction coefficient (mol-1 cm-1)

0.0465 X104

Sandell’s sensitivity

(mcg/cm2-0.001 absorbance units)

0.021

Regression equation (Y*)

Y=0.0092C + 0.0006

Slope (b)

0.0092

Intercept (a)

0.0006

Correlation coefficient(r2)

0.9995

% RSD**

0.648

Limit of detection (mcg/ml)

0.130

Limit of quantitation (mcg/ml)

0.422

*Y= bC + a where C is the concentration of Lamivudine in mcg/ml and

Y is the absorbance at the respective lmax.

**Average of five determinations.

 


 

Table 02: Results of analysis

Brand used

Label claimed(mg)

Amount found by proposed method(mg)

% label claim

% RSD*

Tab-a

100

99.77

99.77

0.86

Tab-b

100

99.56

99.56

1.18

*Average of five determinations.

 

 

Table 03: Results of recovery studies

Brand used

Label claimed(mg)

Mean assay value

Known amount of Lamivudine added

Mean % recovery ±%RSD*

Tab-a

 

100

 

99.77

 

10mg

99.80±1.130

20mg

99.95±1.586

 

Tab-b

100

99.56

10mg

99.88±1.158

20mg

99.74±1.479

*Average of five determinations.

 

 

Table 04: Results of intra day precision studies

Brand used

Label claimed(mg)

Amount found by proposed method(mg)

% label claim

% RSD*

Tab-a

100

99.70

99.70

1.261

Tab-b

100

99.52

99.52

1.188

*Average of five determinations.

 

Table 05: Results of inter day precision studies

Brand used

Label claimed(mg)

Amount found by proposed method(mg)

% label claim

% RSD*

Tab-a

100

99.17

99.17

1.237

Tab-b

100

99.04

99.04

1.121

*Average of five determinations.

 

Table 06: Results of ruggedness studies

Brand used

Label claimed(mg)

Normal condition (Mean assay value)

Changed condition (Mean assay value) ±%RSD*

Tab-a

100

99.77

99.38±1.235

Tab-b

100

99.56

99.21±1.193

*Average of five determinations.


 

Fig. 02- Calibration curve of Lamivudine with β-naphthol.

 

CONCLUSION:

The proposed method is economic, sensitive, accurate, reproducible and useful for the routine determination of Lamivudine in tablet formulation.

 

ACKNOWLEDGMENT:

The authors are grateful to the management of QIS College of Pharmacy for providing the necessary facilities to carry out this work.

 

REFERENCES:

1.       Indian Pharmacopoeia 1996: Addendum 2002. New Delhi: The controller of publications; 2002. p. 918-20.

2.       Hari Krishnan N, Gunasekaran V, Roosewelt C, Vijaya Kumar M, Kalaivani K, Ravichandiran V. Simultaneous estimation of Lamivudine, Zidovudine and Nevirapine by RP-HPLC in pure and pharmaceutical dosage form. Asian J Chem 2008; 20(4):2551-56.

3.       Mangaonkar K, Desai AD. Simultaneous estimation of Lamivudine and Tenofovir disoproxil fumerate in tablets by isocratic RP-HPLC. Indian drugs 2008; 45(2):119-122.

4.       Pai N, Desai AD. Simultaneous RP-HPLC estimation of some antiretroviral drugs from tablets. Indian J Pharm Sci 2007; 69(1):118-120.

5.       Namita K, Sateesh K, Ramesh P. Simultaneous determination of Lamivudine and Stavudine in antiretroviral fixed dose combination by first derivative spectrophotometry and HPLC. J Pharm Biomed Anal 2006; 41(3):761-5.

6.       Namita K, Sateesh K, Ramesh P. Simultaneous determination of Lamivudine, Stavudine and Nevirapine in antiretroviral fixed dose combinations by HPLC. Anal Chim Acta 2006; 570(1):41-5.

7.       Pai N, Desai AD. Simultaneous estimation of some antiretroviral drugs from tablets by HPLC method. Indian drugs 2003; 40(2):111-4.

8.       Pai N, Desai AD. Simultaneous estimation of some antiretroviral drugs from tablets by HPLC method. Indian drugs 2005; 42(10):681-4.

9.       Wankhede SB, Gupta KR, Wadodkar SG. Simultaneous HPTLC estimation of Lamivudine and Stavudine in tablet dosage form. Indian J Pharm Sci 2005:96-7.

 

 

 

Received on 27.01.2010        Modified on 28.03.2010

Accepted on 24.06.2010        © AJRC All right reserved

Asian J. Research Chem. 3(4): Oct. - Dec. 2010; Page 862-864